[HTML][HTML] Impact of COVID-19 in solid organ transplant recipients
L Danziger-Isakov, EA Blumberg, O Manuel… - American Journal of …, 2021 - Elsevier
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early 2020. The …
syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early 2020. The …
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a …
Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient-…
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient-…
[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …
Background The present review is part of the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH) …
Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH) …
Bloodstream infections after solid-organ transplantation
A Kritikos, O Manuel - Virulence, 2016 - Taylor & Francis
Solid-organ transplantation (SOT) has become the preferred strategy to treat a number of
end-stage organ disease, because a continuous improvement in survival and quality of life. …
end-stage organ disease, because a continuous improvement in survival and quality of life. …
[HTML][HTML] COVID-19: a global transplant perspective on successfully navigating a pandemic
The COVID-19 pandemic has rapidly evolved and changed our way of life in an unprecedented
manner. The emergence of COVID-19 has impacted transplantation worldwide. The …
manner. The emergence of COVID-19 has impacted transplantation worldwide. The …
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
Background. It is unknown whether specific viral polymorphisms affect in vivo therapeutic
response in patients with cytomegalovirus (CMV) disease. Polymorphisms in the CMV …
response in patients with cytomegalovirus (CMV) disease. Polymorphisms in the CMV …
Practical dynamic software updating for C
Software updates typically require stopping and restarting an application, but many systems
cannot afford to halt service, or would prefer not to. Dynamic software updating (DSU) …
cannot afford to halt service, or would prefer not to. Dynamic software updating (DSU) …
RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of …
O Manuel, M Estabrook… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the American
Society of Transplantation review the diagnosis, prevention, and management of RNA …
Society of Transplantation review the diagnosis, prevention, and management of RNA …
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients
O Manuel, M Pascual, K Hoschler… - Clinical infectious …, 2011 - academic.oup.com
Background. Few data are available regarding the immunogenicity and safety of the pandemic
influenza vaccine in immunocompromised patients. We evaluated the humoral response …
influenza vaccine in immunocompromised patients. We evaluated the humoral response …
ARTOO: adaptive random testing for object-oriented software
Intuition is often not a good guide to know which testing strategies will work best. There is no
substitute for experimental analysis based on objective criteria: how many faults a strategy …
substitute for experimental analysis based on objective criteria: how many faults a strategy …
